Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Sex hormones affect brain cells differently in males and females.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Sex hormones affect liver fat and metabolic health differently in men and women.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Different reasons for large pores mean treatments need to be personalized.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Retinoic acid affects male and female muscle energy use and function differently.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Hormonal imbalances are important in the development of male pattern baldness.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.